- testing |
No Record Found
Sector
PharmaceuticalsOpen
₹1,390Prev. Close
₹1,391.6Turnover(Lac.)
₹506.01Day's High
₹1,410.8Day's Low
₹1,386.652 Week's High
₹1,519.952 Week's Low
₹889Book Value
₹172.23Face Value
₹10Mkt Cap (₹ Cr.)
26,398.8P/E
60.96EPS
22.83Divi. Yield
0.221 Aug 2025
12:00 AM
AGM
Announcement Date: 01 Aug, 2025
3 Nov 2025
12:00 AM
Board Meeting
Agenda : Audited Result
22 May 2025
12:00 AM
Dividend
Dividend Amount: 3
Record Date: 14 Aug, 2025
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 189.48 | 181.15 | 180.85 | 180.85 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,834.88 | 1,753.95 | 1,661.02 | 1,531.68 |
Net Worth | 3,024.36 | 1,935.1 | 1,841.87 | 1,712.53 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 7,896 | 6,658.25 | 5,985.81 | 5,855.39 | 6,056.42 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 7,896 | 6,658.25 | 5,985.81 | 5,855.39 | 6,056.42 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 67.26 | 56.99 | 45.91 | 63.47 | 35.39 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,799.5 | 92.3 | 4,31,412.42 | 564.22 | 0.89 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,417.5 | 67.76 | 1,70,343.22 | 696 | 0.47 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,728 | 59.13 | 1,26,185.41 | 597 | 0.16 | 2,707 | 249.83 |
Cipla Ltd CIPLA | 1,516.6 | 23.57 | 1,22,510.62 | 1,210.53 | 1.05 | 4,495.16 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,275.2 | 19.73 | 1,06,522.7 | 387.3 | 0.63 | 4,602.9 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole Time Director
MUKUND KESHAO GURJAR
Whole Time Director
SUNIL RAJNIKANT MEHTA
Managing Director & Chief Executive Officer
SATISH RAMANLAL MEHTA
Chairman (Non-Executive)
Berjis M Desai
Whole Time Director
NAMITA VIKAS THAPAR
Independent Director
P S Jayakumar
Independent Director
Vijay Gokhale
Independent Director
Vidya Rajiv Yeravdekar
Independent Director
Shailesh Ayyangar
Whole-time Director
SAMIT SATISH MEHTA
Plot # P-1 & P-2 IT BT Park,
Phase II MIDC Hinjawadi,
Maharashtra - 411057
Tel: +91 20 3507 0033/+91 20 3507 0000
Website: http://www.emcure.com
Email: investors@emcure.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited, as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Re...
Read More
Reports by Emcure Pharmaceuticals Ltd
What is the Emcure Pharmaceuticals Ltd share price today?
What is the Market Cap of Emcure Pharmaceuticals Ltd?
What is the PE and PB ratio of Emcure Pharmaceuticals Ltd?
What is the 52 Week High and Low of Emcure Pharmaceuticals Ltd?
What is the CAGR of Emcure Pharmaceuticals Ltd?
What is the shareholding pattern of Emcure Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.